Thomas Ringbaek1, Eva Brøndum, Gerd Martinez, Peter Lange. 1. Pulmonary Rehabilitation Research Group, Department of Cardiology and Respiratory Medicine, University Hospital of Copenhagen, Hvidovre, Denmark. ringbaek@dadlnet.dk
Abstract
BACKGROUND: The effect of pulmonary rehabilitation on EuroQol in COPD patients has not been investigated previously. METHODS/MATERIALS: Two hundred and twenty nine consecutive COPD patients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit. RESULTS: Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8 units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9 units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ("ceiling effect") for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%). CONCLUSIONS: In COPD patients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a "ceiling effect" of this instrument.
BACKGROUND: The effect of pulmonary rehabilitation on EuroQol in COPDpatients has not been investigated previously. METHODS/MATERIALS: Two hundred and twenty nine consecutive COPDpatients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit. RESULTS: Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8 units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9 units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ("ceiling effect") for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%). CONCLUSIONS: In COPDpatients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a "ceiling effect" of this instrument.
Authors: Manbinder S Sidhu; Amanda Daley; Rachel Jordan; Peter A Coventry; Carl Heneghan; Sue Jowett; Sally Singh; Jennifer Marsh; Peymane Adab; Jinu Varghese; David Nunan; Amy Blakemore; Jenny Stevens; Lee Dowson; David Fitzmaurice; Kate Jolly Journal: BMC Pulm Med Date: 2015-02-22 Impact factor: 3.317
Authors: Marc Miravitlles; Alicia Huerta; Manuel Valle; Patricia García-Sidro; Carles Forné; Carlos Crespo; José Luis López-Campos Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-02-16
Authors: Marc Miravitlles; Alicia Huerta; José Alberto Fernández-Villar; Bernardino Alcázar; Guillermo Villa; Carles Forné; Maribel Cuesta; Carlos Crespo; Francisco García-Río Journal: Health Qual Life Outcomes Date: 2014-09-05 Impact factor: 3.186